Viewing Study NCT05170594


Ignite Creation Date: 2025-12-25 @ 1:46 AM
Ignite Modification Date: 2026-04-24 @ 6:19 PM
Study NCT ID: NCT05170594
Status: UNKNOWN
Last Update Posted: 2021-12-28
First Post: 2021-12-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Bevacizumab Combined With Fluzoparib/Chemotherapy or Fluzoparib in the Treatment of Ovarian Cancer
Sponsor: The Second Affiliated Hospital of Shandong First Medical University
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: MT-004
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators